share_log

Insider Sellers Might Regret Selling Pulmonx Shares at a Lower Price Than Current Market Value

Insider Sellers Might Regret Selling Pulmonx Shares at a Lower Price Than Current Market Value

內幕賣家可能會後悔以低於當前市值的價格出售Pulmonx股票
Simply Wall St ·  04/05 18:44

Pulmonx Corporation's (NASDAQ:LUNG) value has fallen 15% in the last week, but insiders who sold US$661k worth of stock over the last year have had less success. Given that the average selling price of US$10.25 is still lower than the current share price, insiders would probably have been better off keeping their shares.

普爾蒙克斯公司(納斯達克股票代碼:LUNG)的市值在上週下降了15%,但去年出售了價值66.1萬美元股票的內部人士收效不大。鑑於10.25美元的平均售價仍低於當前的股價,內部人士最好保留股票。

Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares.

儘管我們認爲股東不應該簡單地關注內幕交易,但邏輯要求你應該注意內部人士是在買入還是賣出股票。

Pulmonx Insider Transactions Over The Last Year

去年的 Pulmonx 內幕交易

Over the last year, we can see that the biggest insider sale was by the Director, Glendon French, for US$75k worth of shares, at about US$11.49 per share. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. The good news is that this large sale was at well above current price of US$7.86. So it may not tell us anything about how insiders feel about the current share price.

在過去的一年中,我們可以看到,最大的內幕出售是董事格倫登·法蘭西,出售了價值7.5萬美元的股票,每股約11.49美元。儘管內幕拋售是負面的,但對我們來說,如果以較低的價格出售股票,則負面影響更大。好消息是,此次大宗銷售遠高於當前7.86美元的價格。因此,它可能無法告訴我們內部人士對當前股價的看法。

Pulmonx insiders didn't buy any shares over the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!

去年,Pulmonx內部人士沒有購買任何股票。你可以在下面看到過去 12 個月內幕交易(公司和個人)的直觀描述。通過點擊下面的圖表,你可以看到每筆內幕交易的確切細節!

insider-trading-volume
NasdaqGS:LUNG Insider Trading Volume April 5th 2024
納斯達克股票代碼:LUNG 內幕交易量 2024 年 4 月 5 日

If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: insiders have been buying them).

如果你喜歡買內部人士買入而不是賣出的股票,那麼你可能會喜歡這份免費的公司名單。(提示:業內人士一直在購買它們)。

Pulmonx Insiders Are Selling The Stock

Pulmonx 內部人士正在出售該股

The last three months saw significant insider selling at Pulmonx. In total, insiders dumped US$140k worth of shares in that time, and we didn't record any purchases whatsoever. This may suggest that some insiders think that the shares are not cheap.

在過去的三個月中,Pulmonx出現了大量的內幕拋售。在此期間,內部人士總共拋售了價值14萬美元的股票,我們沒有記錄任何購買記錄。這可能表明一些內部人士認爲股票並不便宜。

Insider Ownership Of Pulmonx

Pulmonx 的內部所有權

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Insiders own 4.1% of Pulmonx shares, worth about US$12m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

我喜歡看看內部人士在一家公司擁有多少股票,以幫助我了解他們與內部人士的看法。我認爲,如果內部人士擁有該公司的大量股份,這是一個好兆頭。內部人士擁有Pulmonx4.1%的股份,價值約1200萬美元。儘管這是一個強勁但並不突出的內部所有權水平,但這足以表明管理層與小型股東之間有一定的一致性。

What Might The Insider Transactions At Pulmonx Tell Us?

Pulmonx的內幕交易能告訴我們什麼?

Insiders sold Pulmonx shares recently, but they didn't buy any. Looking to the last twelve months, our data doesn't show any insider buying. While insiders do own shares, they don't own a heap, and they have been selling. We're in no rush to buy! While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. For example - Pulmonx has 3 warning signs we think you should be aware of.

內部人士最近出售了Pulmonx的股票,但他們沒有購買任何股票。展望過去的十二個月,我們的數據並未顯示任何內幕買盤。儘管內部人士確實擁有股票,但他們並不擁有大量股票,他們一直在拋售。我們並不急於購買!雖然我們喜歡了解內部人士的所有權和交易情況,但在做出任何投資決策之前,我們一定要考慮股票面臨的風險。例如,Pulmonx 有 3 個警告信號,我們認爲您應該注意。

But note: Pulmonx may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

但請注意:Pulmonx可能不是最值得購買的股票。因此,來看看這份投資回報率高、負債率低的有趣公司的免費清單。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,內部人士是指向相關監管機構報告其交易的個人。我們目前只考慮公開市場交易和私下處置的直接利益,不包括衍生品交易或間接權益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論